A new study by UCLA Health has discovered what researchers say is the first drug to fully reproduce the effects of physical ...
Researchers, executives, and thought leaders across healthcare gathered at NVIDIA GTC to discuss today’s pressing AI life science applications.
Ignota Labs is using AI to fix failed drugs and bring them to market. It raised $6.9 million from investors with this pitch ...
This comprehensive review analyzes cutting-edge tools and technologies in modern pharmaceutical research, focusing on ...
It’s doing something that sounds like it’s from a sci-fi novel: creating virtual reality clones of patients for interactions.
A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...
The first time Dr. Fajgenbaum repurposed a drug, it was in an attempt to save his own life. At 25, while in medical school, ...
A man on pre-trial release in a November drug case was found driving a stolen vehicle with methamphetamine this week, according to a magistrate’s complaint filed in Superior Court. Scott Martin ...
The trial's topline-data results, which are expected in the second half of 2025, are intended to support a potential supplemental new drug application submission to expand the label of the Food ...
The 32-year-old could face a firing squad if he is found guilty of trying to push the 1.055kg of Class A drugs police say they recovered in a mail package. MDMA is the main component in the party ...
One in 6 patients in phase 2 cancer trials received treatments that were eventually approved by the US Food and Drug Administration (FDA), a new analysis found. This proportion increased to 1 in 5 ...
A depression drug candidate that’s a key part of Johnson & Johnson’s neuroscience strategy has failed a Phase 3 clinical trial, the latest dose of disappointing news for an emerging class of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results